Financials Guangdong Transtek Medical Electronics Co., Ltd

Equities

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 26/04/2024 am IST			5-day change	1st Jan Change
8.85 ^CNY	+1.61%		+7.27%	-22.44%

24/04	Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/04	Transtek Medical Electronics Gets Nod to Sell Blood Pressure Monitoring Device in Canada	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	2,858	4,147	3,516	2,439	2,475	1,920	-	-
Enterprise Value (EV) ¹	2,858	4,147	3,516	2,439	2,475	1,920	1,920	1,920
P/E ratio	94.6 x	59.2 x	412 x	-75.7 x	71.4 x	34.7 x	26.8 x	21.1 x
Yield	-	-	-	-	-	0.45%	0.56%	0.68%
Capitalization / Revenue	3.23 x	3.1 x	1.93 x	-	2.8 x	1.67 x	1.31 x	1.02 x
EV / Revenue	3.23 x	3.1 x	1.93 x	-	2.8 x	1.67 x	1.31 x	1.02 x
EV / EBITDA	52.4 x	46 x	160 x	-	39.7 x	26 x	19 x	15.3 x
EV / FCF	-	-	-	-	-	45.7 x	25.9 x	20.2 x
FCF Yield	-	-	-	-	-	2.19%	3.86%	4.95%
Price to Book	5.06 x	6.37 x	3.35 x	-	2.38 x	1.78 x	1.71 x	1.61 x
Nbr of stocks (in thousands)	1,88,800	1,89,430	2,13,480	2,14,701	2,16,901	2,16,901	-	-
Reference price ²	15.14	21.89	16.47	11.36	11.41	8.850	8.850	8.850
Announcement Date	28/02/20	21/02/21	18/03/22	27/04/23	25/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	883.7	1,337	1,821	-	884.3	1,148	1,468	1,884
EBITDA ¹	54.55	90.1	21.91	-	62.4	73.81	101.1	125.8
EBIT ¹	37.64	72.17	0.0852	-	34.53	56.04	71.02	89.56
Operating Margin	4.26%	5.4%	0%	-	3.9%	4.88%	4.84%	4.75%
Earnings before Tax (EBT) ¹	36.85	71.93	-3.209	-	33.11	53.18	68.26	87.44
Net income ¹	31.06	70.16	8.869	-32.29	34.37	55.28	71.2	90.72
Net margin	3.52%	5.25%	0.49%	-	3.89%	4.82%	4.85%	4.82%
EPS ²	0.1600	0.3700	0.0400	-0.1500	0.1597	0.2550	0.3300	0.4200
Free Cash Flow ¹	-	-	-	-	-	42	74	95
FCF margin	-	-	-	-	-	3.66%	5.04%	5.04%
FCF Conversion (EBITDA)	-	-	-	-	-	56.9%	73.18%	75.5%
FCF Conversion (Net income)	-	-	-	-	-	75.98%	103.94%	104.71%
Dividend per Share ²	-	-	-	-	-	0.0400	0.0500	0.0600
Announcement Date	28/02/20	21/02/21	18/03/22	27/04/23	25/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	-	-	42	74	95
ROE (net income / shareholders' equity)	5.62%	11.5%	0.9%	-	3.35%	4.93%	6.13%	7.38%
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	2.990	3.440	4.920	-	4.800	4.960	5.190	5.500
Cash Flow per Share ²	0.3900	0.4100	-0	-	0.3400	0.6600	0.1500	1.420
Capex ¹	31.7	99.3	67.8	-	12.1	122	111	110
Capex / Sales	3.59%	7.43%	3.72%	-	1.37%	10.63%	7.54%	5.85%
Announcement Date	28/02/20	21/02/21	18/03/22	27/04/23	25/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.85 CNY

Average target price

12.75 CNY

Spread / Average Target

+44.07%

	1st Jan change	Capi.
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD	-22.44%	265M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B